Characterizing visual read tau‐PET‐negative participants with Alzheimer's disease dementia

We used the novel Food and Drug Administration (FDA)-approved VR method for defining tau-PET positivity. AD A+T- patients were older and showed less atrophy and cognitive decline than AD A+T+. We did not find convincing evidence of tau accumulation in AD A+T- or copathologies. The group of AD A+T- patients is likely very heterogeneous.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-04-01
DOI
https://doi.org/10.1002/alz.14423
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterizing visual read tau‐PET‐negative participants with Alzheimer's disease dementia

Roos M. Rikken, Rik Ossenkoppele, Philip Scheltens, Denise Visser et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Characterizing visual read tau‐PET‐negative participants with Alzheimer's disease dementia

Roos M. Rikken, Rik Ossenkoppele, Philip Scheltens, Denise Visser, Ronald Boellaard, Pieter Jelle Visser, Wiesje M. van der Flier, Emma M. Coomans, Elsmarieke van de Giessen, Anouk den Braber, Frederik Barkhof, Sandeep S.V. Golla, Everard G.B. Vijverberg, Lyduine E. Collij, Lotte A. de Koning, Eline Neutelings
article en

Abstract

We used the novel Food and Drug Administration (FDA)-approved VR method for defining tau-PET positivity. AD A+T- patients were older and showed less atrophy and cognitive decline than AD A+T+. We did not find convincing evidence of tau accumulation in AD A+T- or copathologies. The group of AD A+T- patients is likely very heterogeneous.

Alzheimer s & DementiaVol. 21(4)
Lund University (SE), Karolinska Institutet (SE), Maastricht University (NL), Amsterdam Neuroscience (NL), National Hospital for Neurology and Neurosurgery (GB), Amsterdam University Medical Centers (NL), University College London (GB), Vrije Universiteit Amsterdam (NL)
Alzheimer's Disease Neuroimaging Initiative, European Federation of Pharmaceutical Industries and Associations, European Commission, ZonMw, Stichting Dioraphte, Alzheimer Nederland, Amsterdam Neuroscience, National Institutes of Health, National Institute on Aging, National Institute of Biomedical Imaging and Bioengineering, Janssen Pharmaceuticals
Openalex Percentile: Top 90%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.